Fundraising FoxNaDeNo
Oslo, NO · 3 known investors
Find your way into NaDeNo
Sign up to see every warm intro you have to NaDeNo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NaDeNo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NaDeNo develops nanoparticle drug delivery technology that encapsulates hard-to-deliver molecules through a proprietary one-step process without chemical modification. The platform serves pharmaceutical companies and biotech partners seeking to improve formulation of poorly soluble or hydrophobic therapeutics.
Founders & leadership
YM
Yrr MørchCo-founder & Chief Technology OfficerCo-founder and CTO of NaDeNo, which develops nanoparticle drug delivery technology for encapsulating hard-to-deliver molecules. Mørch's expertise spans nanomedicine, biopolymer chemistry, nanoparticle characterization, and related areas such as controlled release, microfluidics, and imaging contrast agents.
Investors · 3
In the news
Frequently asked questions
- What does NaDeNo do?
- NaDeNo develops nanoparticle drug delivery technology that encapsulates hard-to-deliver molecules through a proprietary one-step process without chemical modification. The platform serves pharmaceutical companies and biotech partners seeking to improve formulation of poorly soluble or hydrophobic therapeutics.
- Who founded NaDeNo?
- NaDeNo was founded by Annbjørg Falck, Yrr Mørch.
- Who are NaDeNo's investors?
- NaDeNo's investors include Farvatn Venture, Planet 9 Capital, Sondo Capital.
- Where is NaDeNo headquartered?
- NaDeNo is headquartered in Oslo, NO.